Smart-Money SignalDistribution · 26/100— Insiders are net sellers over 90 days (-$79.0M, 138 sales vs 18 buys)
Revenue$696.6M
Net Income-$85.1M
EPS$-0.60
Market Cap$40.2B
Price Performance
Historical data including institutional events
Company Profile
S
Steve Chapman
CEO & Executive Director
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas.
